Cogent Biosciences
COGT
COGT
146 hedge funds and large institutions have $734M invested in Cogent Biosciences in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
10% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 30
1% more funds holding
Funds holding: 144 → 146 (+2)
2.93% less ownership
Funds ownership: 108.08% → 105.14% (-2.9%)
Holders
146
Holding in Top 10
4
Calls
$1.76M
Puts
$1.13M
Top Buyers
| 1 | +$23.4M | |
| 2 | +$17.8M | |
| 3 | +$16.1M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$14M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.2M |
Top Sellers
| 1 | -$22.8M | |
| 2 | -$17.9M | |
| 3 | -$13.1M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$7.11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.42M |